The landscape of managing diabetes is changing with the emergence of GLP-1 patches . These novel patches offer a potentially less invasive alternative to injections for individuals living with diabetes mellitus type 2 . They deliver glucagon-like peptide-1 directly through the skin , circumventing the need for daily injections and possibly enhancin